Ofloxacin Ip

Here are the key specifications outlined in the IP monograph for Ofloxacin:

Identification: Methods to confirm the presence and purity of Ofloxacin ensuring it meets defined standards without contamination from other substances.

Assay: Quantitative determination of the potency of Ofloxacin typically expressed as a percentage of the labeled amount ensuring consistency in therapeutic efficacy.

Related Substances: Limits on impurities and degradation products to maintain purity and safety.

Residual Solvents: Maximum allowable levels of solvents used in manufacturing ensuring the final product is free from harmful residues.

Loss on Drying: Measurement of moisture content to prevent degradation and ensure stability throughout storage and use.

Heavy Metals: Strict limits on toxic heavy metals such as lead arsenic mercury and cadmium to ensure product safety.

Microbial Limits: Specifications ensuring the absence of harmful microorganisms maintaining microbiological purity.

Particle Size Distribution: Requirements for particle size uniformity to optimize dissolution and absorption enhancing bioavailability.

Uniformity of Dosage Units: Criteria ensuring consistent dosage across individual tablets or capsules crucial for treatment efficacy.

Packaging: Specifications for materials and labeling that preserve the integrity and stability of Ofloxacin during storage and distribution.